Baiteng Zhao - 17 Jun 2025 Form 4 Insider Report for Whitehawk Therapeutics, Inc. (WHWK)

Role: Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: WHWK
Transactions as of: 17 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 17 Jun 2025, 20:10:46 UTC
Previous filing: 04 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zhao Baiteng	Director	C/O WHITEHAWK THERAPEUTICS, INC., MORRISTOWN	/s/ Stephen Rodin, as Attorney-in-Fact	17 Jun 2025	0002049287

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WHWK	Stock Option (right to buy)	Award	$0	+40,006		$0.000000	40,006	17 Jun 2025	Common Stock	40,006	$2.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2025.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2025.